Page last updated: 2024-10-22

alendronate and Scleroderma, Diffuse

alendronate has been researched along with Scleroderma, Diffuse in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Scleroderma, Diffuse: A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.

Research Excerpts

ExcerptRelevanceReference
"Bone resorption was increased in patients with connective tissue disease and severe dystrophic calcification."1.32Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification. ( Bresnihan, B; FitzGerald, O; Freaney, R; McKenna, M; Murphy, E, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, E1
Freaney, R1
Bresnihan, B1
McKenna, M1
FitzGerald, O1

Other Studies

1 other study available for alendronate and Scleroderma, Diffuse

ArticleYear
Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification.
    Calcified tissue international, 2003, Volume: 73, Issue:5

    Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Resorption; Calcino

2003